271 related articles for article (PubMed ID: 24729396)
1. Regulatory B cells are numerically but not functionally deficient in anti-neutrophil cytoplasm antibody-associated vasculitis.
Todd SK; Pepper RJ; Draibe J; Tanna A; Pusey CD; Mauri C; Salama AD
Rheumatology (Oxford); 2014 Sep; 53(9):1693-703. PubMed ID: 24729396
[TBL] [Abstract][Full Text] [Related]
2. Altered B cell balance, but unaffected B cell capacity to limit monocyte activation in anti-neutrophil cytoplasmic antibody-associated vasculitis in remission.
Lepse N; Abdulahad WH; Rutgers A; Kallenberg CG; Stegeman CA; Heeringa P
Rheumatology (Oxford); 2014 Sep; 53(9):1683-92. PubMed ID: 24729403
[TBL] [Abstract][Full Text] [Related]
3. Regulatory B cells in ANCA-associated vasculitis.
Wilde B; Thewissen M; Damoiseaux J; Knippenberg S; Hilhorst M; van Paassen P; Witzke O; Cohen Tervaert JW
Ann Rheum Dis; 2013 Aug; 72(8):1416-9. PubMed ID: 23666929
[TBL] [Abstract][Full Text] [Related]
4. Reduced CD5(+) CD24(hi) CD38(hi) and interleukin-10(+) regulatory B cells in active anti-neutrophil cytoplasmic autoantibody-associated vasculitis permit increased circulating autoantibodies.
Aybar LT; McGregor JG; Hogan SL; Hu Y; Mendoza CE; Brant EJ; Poulton CJ; Henderson CD; Falk RJ; Bunch DO
Clin Exp Immunol; 2015 May; 180(2):178-88. PubMed ID: 25376552
[TBL] [Abstract][Full Text] [Related]
5. CD14 expression is increased on monocytes in patients with anti-neutrophil cytoplasm antibody (ANCA)-associated vasculitis and correlates with the expression of ANCA autoantigens.
Tarzi RM; Liu J; Schneiter S; Hill NR; Page TH; Cook HT; Pusey CD; Woollard KJ
Clin Exp Immunol; 2015 Jul; 181(1):65-75. PubMed ID: 25766482
[TBL] [Abstract][Full Text] [Related]
6. Decreased CD5⁺ B cells in active ANCA vasculitis and relapse after rituximab.
Bunch DO; McGregor JG; Khandoobhai NB; Aybar LT; Burkart ME; Hu Y; Hogan SL; Poulton CJ; Berg EA; Falk RJ; Nachman PH
Clin J Am Soc Nephrol; 2013 Mar; 8(3):382-91. PubMed ID: 23293123
[TBL] [Abstract][Full Text] [Related]
7. Extended versus standard azathioprine maintenance therapy in newly diagnosed proteinase-3 anti-neutrophil cytoplasmic antibody-associated vasculitis patients who remain cytoplasmic anti-neutrophil cytoplasmic antibody-positive after induction of remission: a randomized clinical trial.
Sanders JS; de Joode AA; DeSevaux RG; Broekroelofs J; Voskuyl AE; van Paassen P; Kallenberg CG; Tervaert JW; Stegeman CA
Nephrol Dial Transplant; 2016 Sep; 31(9):1453-9. PubMed ID: 27242368
[TBL] [Abstract][Full Text] [Related]
8. The immune balance between memory and regulatory B cells in NMO and the changes of the balance after methylprednisolone or rituximab therapy.
Quan C; ZhangBao J; Lu J; Zhao C; Cai T; Wang B; Yu H; Qiao J; Lu C
J Neuroimmunol; 2015 May; 282():45-53. PubMed ID: 25903728
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type.
Unizony S; Villarreal M; Miloslavsky EM; Lu N; Merkel PA; Spiera R; Seo P; Langford CA; Hoffman GS; Kallenberg CM; St Clair EW; Ikle D; Tchao NK; Ding L; Brunetta P; Choi HK; Monach PA; Fervenza F; Stone JH; Specks U;
Ann Rheum Dis; 2016 Jun; 75(6):1166-9. PubMed ID: 26621483
[TBL] [Abstract][Full Text] [Related]
10. B cell subsets and dysfunction of regulatory B cells in IgG4-related diseases and primary Sjögren's syndrome: the similarities and differences.
Lin W; Jin L; Chen H; Wu Q; Fei Y; Zheng W; Wang Q; Li P; Li Y; Zhang W; Zhao Y; Zeng X; Zhang F
Arthritis Res Ther; 2014 May; 16(3):R118. PubMed ID: 24887143
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and Safety of Belimumab and Azathioprine for Maintenance of Remission in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Randomized Controlled Study.
Jayne D; Blockmans D; Luqmani R; Moiseev S; Ji B; Green Y; Hall L; Roth D; Henderson RB; Merkel PA;
Arthritis Rheumatol; 2019 Jun; 71(6):952-963. PubMed ID: 30666823
[TBL] [Abstract][Full Text] [Related]
12. Deficit of circulating CD19
Zaimoku Y; Patel BA; Kajigaya S; Feng X; Alemu L; Quinones Raffo D; Groarke EM; Young NS
Br J Haematol; 2020 Aug; 190(4):610-617. PubMed ID: 32311088
[TBL] [Abstract][Full Text] [Related]
13. B cell homeostasis is disturbed by immunosuppressive therapies in patients with ANCA-associated vasculitides.
Thiel J; Salzer U; Hässler F; Effelsberg NM; Hentze C; Sic H; Bartsch M; Miehle N; Peter HH; Warnatz K; Schlesier M; Voll RE; Venhoff N
Autoimmunity; 2013 Nov; 46(7):429-38. PubMed ID: 23742274
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B Vaccine Non-Responders Show Higher Frequencies of CD24
Körber N; Pohl L; Weinberger B; Grubeck-Loebenstein B; Wawer A; Knolle PA; Roggendorf H; Protzer U; Bauer T
Front Immunol; 2021; 12():713351. PubMed ID: 34566969
[TBL] [Abstract][Full Text] [Related]
15. Frequency and immunophenotype of IL10-producing regulatory B cells in optic neuritis.
Lundqvist S; Modvig S; Fischer EA; Frederiksen JL; Degn M
Immunology; 2019 Mar; 156(3):259-269. PubMed ID: 30452090
[TBL] [Abstract][Full Text] [Related]
16. B-cell therapy in antineutrophil cytoplasmic antibody-associated vasculitis.
Kallenberg CG; Hauser T
Nephrol Dial Transplant; 2015 Apr; 30 Suppl 1():i119-22. PubMed ID: 25753806
[TBL] [Abstract][Full Text] [Related]
17. Factors Determining the Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3.
Fussner LA; Hummel AM; Schroeder DR; Silva F; Cartin-Ceba R; Snyder MR; Hoffman GS; Kallenberg CG; Langford CA; Merkel PA; Monach PA; Seo P; Spiera RF; William St Clair E; Tchao NK; Stone JH; Specks U;
Arthritis Rheumatol; 2016 Jul; 68(7):1700-10. PubMed ID: 26882078
[TBL] [Abstract][Full Text] [Related]
18. Highly Sensitive Flow Cytometric Detection of Residual B-Cells After Rituximab in Anti-Neutrophil Cytoplasmic Antibodies-Associated Vasculitis Patients.
van Dam LS; Oskam JM; Kamerling SWA; Arends EJ; Bredewold OW; Berkowska MA; van Dongen JJM; Rabelink TJ; van Kooten C; Teng YKO
Front Immunol; 2020; 11():566732. PubMed ID: 33384685
[TBL] [Abstract][Full Text] [Related]
19. Dampening of CD8+ T Cell Response by B Cell Depletion Therapy in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Néel A; Bucchia M; Néel M; Tilly G; Caristan A; Yap M; Rimbert M; Bruneau S; Cadoux M; Agard C; Hourmant M; Godmer P; Brouard S; Bressollette C; Hamidou M; Josien R; Fakhouri F; Degauque N
Arthritis Rheumatol; 2019 Apr; 71(4):641-650. PubMed ID: 30375745
[TBL] [Abstract][Full Text] [Related]
20. Altered Regulatory B Cell Subsets in Children with Type 1 Diabetes Mellitus.
El-Mokhtar MA; Elsherbiny NM; Sayed D; Raafat DM; Askar E; Hussein A; Abdel-Malek MAY; Shalaby AM
J Immunol Res; 2020; 2020():8935694. PubMed ID: 32775471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
